SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,821 | -8.9% | 345 | -14.0% | 0.01% | -11.1% |
| Q2 2023 | $45,922 | -16.9% | 401 | 0.0% | 0.01% | -18.2% |
| Q1 2023 | $55,270 | +25.6% | 401 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $44,000 | +46.7% | 401 | 0.0% | 0.01% | +37.5% |
| Q2 2022 | $30,000 | -11.8% | 401 | -7.6% | 0.01% | 0.0% |
| Q1 2022 | $34,000 | -20.9% | 434 | -8.4% | 0.01% | -11.1% |
| Q4 2021 | $43,000 | -2.3% | 474 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $44,000 | +25.7% | 474 | +4.6% | 0.01% | +22.2% |
| Q2 2021 | $35,000 | – | 453 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |